Tech Company Financing Transactions

Rhythm Pharmaceuticals Funding Round

Rhythm Pharmaceuticals, based in Boston, received $19 million in investment from MPM Capital, New Enterprise Associates and Third Rock Ventures.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

222 Berkeley St. 12th Floor
Boston, MA 02116
USA

Phone

(857) 264-4280

Website

www.rhythmtx.com

Email Address

[email protected]

Overview

Rhythm (NASDAQ: RYTM) is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Meeker

        

Chief Financial Officer

Hunter Smith

        

Chief Medical Officer

Murray Stewart

        

Executive Vice President

Jennifer Chien

        

Executive Vice President

Yann Mazabraud

        

VP - Human Resources

Simon Kelner

        

Browse more venture capital transactions:

Prev: 9/8/2010: Expensify venture capital transaction
Next: 9/8/2010: ByAllAccounts venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary